Brain Scanning Technology to be Used for Psychedelic Clinical Trials in Pioneering London Start-Up Partnership
A start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic clinical trials.
A start-up partnership between Clerkenwell Health and MYndspan will use brain scanning technology for psychedelic clinical trials.
A partnership between Clerkenwell Health and Transpharmation provides drug developers a one-stop-shop for all stages of psychedelic research.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.